Contemporary OB/GYN week in review: mifepristone, bacterial vaginosis, and more

Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, February 26 - Friday, March 01 2024), and click each link to read and watch anything you may have missed.

1.) Walgreens and CVS to distribute mifepristone

Walgreens and CVS pharmacies are set to dispense mifepristone in select states, aiming to address legal complexities and enhance accessibility amidst ongoing regulatory and legal battles.

Click here for the full article.

2.) Demystifying bacterial vaginosis: Understanding, treatment, and breaking stigmas

Misunderstandings surrounding bacterial vaginosis can delay treatment, but advancements such as XACIATO offer effective solutions, emphasizing the importance of open communication and continued research for comprehensive women's health care.

Click here for the full article.

3.) Unveiling metabolic markers of Candida albicans infection

Discover how metabolomics sheds light on potential biomarkers for early detection and treatment of Candida albicans-induced vulvovaginal candidiasis, offering crucial insights into the pathogenesis of this prevalent inflammatory condition.

Click here for the full article.

4.) 6 Strategies to Improve Antenatal HIV, HBV, Syphilis Screening

A recent systematic review highlighted a half-dozen methods to improve antenatal STI screening in low- and middle-income countries in need of better options.

Click here for the full article.

5.) Placental oxygenation's link to fetal brain volumes

Discover how transverse relaxation time mapping, a sensitive magnetic resonance imaging-based technique, unveils the relationship between placental oxygenation and fetal brain development, shedding light on potential biomarkers for assessing fetal well-being.

Click here for the full article.